Screening at any cost?

نویسنده

  • Roger Ladouceur
چکیده

Can we increase screening participation, and if so, at what cost? These were the questions I asked myself while reading the article “Effect of provider and patient reminders, deployment of nurse practitioners, and financial incentives on cervical and breast cancer screening rates,” which appears on page e282 of this issue.1 Kaczorowski et al present the results of a large concerted effort that took place in Ontario from 2004 to 2005, which aimed to increase the number of screening participants in both Papanicolaou tests for cervical cancer and mammograms for breast cancer.1 The goal of the program, known as P-PROMPT (Provider and Patient Reminders in Ontario: Multi-strategy Prevention Tools), which was supported by the Primary Health Care Transition Fund, was to develop and evaluate a large-scale demonstration project aimed at increasing delivery of 4 targeted preventive care services by means of the newly created models of primary care (primary care networks [PCNs] and family health networks [FHNs]); the preventive care management program; recall and reminder systems; and deployment of nurse practitioners (NPs) to enhance delivery of preventive care services. Kaczorowski et al conducted a large study: 232 Ontario family physicians participated, representing 75% of those practising in PCNs and FHNs in southwestern Ontario.1 A total of 83 101 women aged 35 to 69 were targeted for Pap tests every 2 years and 39 780 women between the ages of 50 and 69 were targeted for mammograms every 2 years. Six NPs were deployed to the PCNs and FHNs, working specifically to reach the targets. Subsidies were given to doctors to encourage them to attain the prevention targets—yearly bonuses of up to $2200 were offered for meeting objectives, and expenses related to reminders were eligible for reimbursement—and thousands of letters and other specific reminders were sent to patients who “forgot.” Is all of this worth it? After 1 year, statistically significant increases of 6% for Pap test rates and 5% for mammogram rates were noted (P < .001 for both). Any measure that achieves an increase in preventive behaviour is certainly valuable, but are these results really significant? In fact, when we consider participation rates in cervical and breast cancer screening programs, we observe that they already oscillate between 60% and 70%.2 The women targeted by the program initially had high participation rates—70% already participated in breast cancer screening and almost 69% regularly had Pap tests. The P-PROMPT program increased participation from 70% to 75% for breast cancer screening and 69% to 75% for cervical cancer screening. Even if the results seem impressive, one must recognize that most women who did not subscribe to the initial screenings continued to resist participating. In fact, the program succeeded in convincing 5% of 39 279 women to undergo breast cancer screening and 6% of 74 283 women to undergo Pap tests, which corresponded to 2085 and 4664 women, respectively. On the other hand, 9682 and 18 429 women refused to undergo mammograms and Pap tests, respectively. Therefore, we cannot ignore the fact that 25% of the women chose not to participate in these widely recognized and well-established preventive measures. This study demonstrates that we can increase the participation rate for screening programs. It also demonstrates the limitations of our educational efforts. Even if we invest thousands of dollars in educational campaigns, put into place every imaginable computerized or personalized reminder service, hire a multitude of NPs, and subsidize preventive practices, there will always remain a substantial proportion of the population that will ignore our interventions. In our health care system, which shows cracks everywhere, we should seriously question where we want to invest our funds. Everyone will claim that their practices are essential. Radiologists will tell us how important it is to achieve a screening rate above 70% and gastroenterologists will say the same about colonoscopies; others will express the importance of wearing a helmet while cycling. In contrast, others will say, justifiably, that it makes no sense to be unable to find a family doctor, to wait in an emergency department for hours, to spend days on a gurney in a hallway, or to wait several months for major surgery. As human and financial resources are not unlimited, we will have to prioritize. At the risk of displeasing advocates of prevention at all cost, educational and preventive measures will have to, like all other measures, be the object of efficiency analysis.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Economic Appraisal of Urine Opiates Screening Test: A Study in Kerman, Iran

Background: Cost effectiveness, the ratio of relative costs of a program to its desired outcomes, is one of the basic issues in various screening programs performed to detect opium abuse. This study aimed to find the cost-effectiveness of opiates abuse screening through urine analysis. Methods: A total number of 64698 individuals were selected and divided into to five distinct groups based on t...

متن کامل

Economic Evaluation of Screening for Type 2 Diabetes: Case Study of Iran

Abstract Objective: In health economics, one of the important methods of economic evaluation is cost-effectiveness analysis. The usual procedure in this method is to consider effectiveness of Disability-Adjusted Life Years (DALYs) as a measure criterion. Material and Methods: This was a cross sectional study of economic assessment type or Cost-Effectiveness. All over 30 years old population o...

متن کامل

هزینه – اثربخشی  بکارگیری کارشناسان بینائی سنجی  بجای مربیان آموزش دیده در

Background and Aim: Amblyopia is an important cause of weak vision and blindness. A preliminary study on validity of the current screening program in Shahrood City's kindergartens showed that this method may not be efficient enough, especially because of low sensitivity and referral problems. We tried to compare efficiencies and costs of screening by trained staff and optometrists in detecting ...

متن کامل

Cost-effectiveness of pap smear screening for vaginal cancer after total hysterectomy for benign disease.

OBJECTIVE To examine the cost effectiveness of Papanicolaou screening for cancer after total hysterectomy for benign disease. MATERIALS AND METHODS Decision analysis including Markov modeling applied to women aged 40 or older with a history of total hysterectomy for benign disease. We derived expected discounted costs and life expectancy. RESULTS Maximum gain in life expectancy between no s...

متن کامل

The Effectiveness of Health Screening.

Using a matched insurant-general practitioner panel data set, we estimate the effect of a general health-screening program on individuals' health status and health-care cost. To account for selection into treatment, we use regional variation in the intensity of exposure to supply-determined screening recommendations as an instrumental variable. We find that screening participation increases inp...

متن کامل

Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. A cost-effectiveness analysis of three strategies.

BACKGROUND Screening women for Chlamydia trachomatis in family planning clinics is associated with a reduced incidence of chlamydial sequelae. However, the question of whom to screen to maintain efficient use of resources remains controversial. OBJECTIVE To assess the cost-effectiveness of chlamydial screening done according to three sets of criteria in asymptomatic women attending family pla...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Canadian family physician Medecin de famille canadien

دوره 59 6  شماره 

صفحات  -

تاریخ انتشار 2013